| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_93e8f3f0e161df3d09d4b9a837a21e23 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-14 |
| filingDate |
2007-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2011-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41cc3d1d1a4bc77723e6aeecb3b5237c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31da9eb9d089f2ef5a918a925ba210c2 |
| publicationDate |
2011-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2369296-T3 |
| titleOfInvention |
CONCENTRATED LIQUID COMPOSITION OF THYROID HORMONE. |
| abstract |
A liquid pharmaceutical composition, in which the composition comprises: at least one thyroid hormone, from about 10% to about 50% (by weight) of hydroxypropyl-β-cyclodextrin, at least one buffer, and at least 5% (by weight ) of water; and the pH of the composition is 8 to 1 |
| priorityDate |
2006-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |